Initial Workup for Hyperparathyroidism with Mild Hypercalcemia
The initial workup for hyperparathyroidism with mild hypercalcemia should include measurement of serum calcium, phosphorus, intact PTH, 25-hydroxyvitamin D, and assessment of renal function with creatinine and estimated GFR. 1
Key Laboratory Tests
- Serum calcium: Confirm hypercalcemia with repeat measurement
- Ionized calcium: More accurate reflection of physiologically active calcium
- Intact PTH: Essential to distinguish PTH-dependent from PTH-independent causes
- Use appropriate generation assay (second or third-generation) 2
- Serum phosphorus: Typically low in primary hyperparathyroidism
- 25-hydroxyvitamin D: To rule out vitamin D deficiency as a cause of secondary hyperparathyroidism
- Renal function tests: Creatinine and estimated GFR
- 24-hour urine calcium: To differentiate primary hyperparathyroidism from familial hypocalciuric hypercalcemia
- Serum albumin: For corrected calcium calculation
Imaging Studies
After biochemical confirmation of primary hyperparathyroidism:
- Neck ultrasound: First-line imaging to locate parathyroid adenoma
- Sestamibi scan: If ultrasound is negative or inconclusive
- Bone mineral density: To assess for skeletal involvement (particularly at distal radius, lumbar spine, and hip)
- Renal imaging: To evaluate for nephrolithiasis or nephrocalcinosis if clinically indicated
Diagnostic Algorithm
- Confirm hypercalcemia with repeat measurement
- Measure intact PTH:
- Elevated or inappropriately normal PTH with hypercalcemia suggests primary hyperparathyroidism
- Suppressed PTH (<20 pg/mL) suggests non-PTH mediated hypercalcemia (malignancy, granulomatous disease, etc.) 1
- Assess vitamin D status to rule out vitamin D deficiency
- Calculate fractional excretion of calcium using 24-hour urine calcium and creatinine
- Low urinary calcium (<100 mg/24h) suggests familial hypocalciuric hypercalcemia
- High urinary calcium (>250 mg/24h) is typical of primary hyperparathyroidism
Common Pitfalls to Avoid
- Not repeating calcium measurement: Single elevated calcium value may be spurious
- Ignoring vitamin D status: Vitamin D deficiency can mask the severity of primary hyperparathyroidism
- Using incorrect PTH assay: Different generations of PTH assays measure different fragments, affecting interpretation 2
- Failing to calculate urinary calcium excretion: Essential to rule out familial hypocalciuric hypercalcemia
- Not considering medication effects: Thiazide diuretics, lithium, and calcium/vitamin D supplements can affect calcium levels 1
Target Values and Monitoring
For patients with confirmed primary hyperparathyroidism:
- Target PTH levels vary by CKD stage:
- CKD G3: <70 pg/mL
- CKD G4: <110 pg/mL
- CKD G5: <300 pg/mL
- CKD G5D: 150-600 pg/mL 3
For mild asymptomatic hyperparathyroidism, monitoring should occur every 3-6 months initially, then every 6-12 months once stable, to assess calcium, phosphorus, and PTH levels and to monitor for complications such as bone disease, kidney stones, and cardiovascular calcifications 3.